封面
市场调查报告书
商品编码
1424302

医用人造材料市场:按产品类型、按应用、按最终用户、按地区

Medical Engineered Materials Market, By Product Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 130 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球医用人造材料市场预计将从2023年的196.6亿美元增加到2030年的501.1亿美元,预测期内复合年增长率为14.3%。

报告范围 报告详情
基准年 2022年 2023/2024年市场规模 196.6亿美元
实际资料 2018-2021 预测期 2023-2030
2023/2024-2030/2031预测期复合年增长率 14.30% 2030/2031价值预测 501.1亿美元
图 1. 2023 年按地区分類的医用人造材料全球市场占有率(%)
医疗工程材料市场-IMG1

医用工程材料在医疗产业中发挥着重要作用,为广泛的应用提供创新的解决方案。这些材料经过专门设计,以满足医疗设备、植入和设备的独特要求。它们具有卓越的强度、耐用性和生物相容性,确保安全有效的医疗解决方案。材料科学和工程的重大进步扩大了陶瓷、金属、聚合物和复合材料等材料在医学中的使用。新型生物工程材料正在开发中,可以密切模仿人体组织并有助于组织再生。这些进步是由医疗程序和治疗日益复杂以及改善患者治疗效果的需求所推动的。总体而言,医疗工程材料产业在开发创新材料解决方案以将医疗保健提升到新水平方面发挥关键作用。

市场动态:

全球医用人造材料市场的成长受到多种因素的推动。心血管疾病、糖尿病和癌症等慢性疾病的日益普及预计将推动对医疗设备和植入的需求。这些材料具有生物相容性、耐用性和弹性等优异特性,使其对于先进医疗设备的开发至关重要。全球老年人口的增加正在推动市场成长。医用人造材料的使用是必要的,因为老年人更容易患慢性病,需要专门的医疗。此外,材料科学的技术进步,例如基于奈米技术的生物基材料和涂料的开发,正在进一步推动市场成长。

然而,市场面临一些挑战。美国食品药物管理局(FDA) 等监管机构实施的严格法规和品质标准可能成为市场进入者的障碍。遵守这些法规并获得新材料的监管核准既耗时又昂贵。此外,与医用人造材料的开发和製造相关的高成本可能会抑制因素市场成长。

本研究的主要特点

  • 本研究报告对全球医用人造材料市场进行了详细分析,并提供了以2022年为基准年的预测期(2023-2030年)的市场规模和年复合成长率(CAGR%)。
  • 它还阐明了各个细分市场的潜在商机,并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数,介绍了全球医用人造材料市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
  • 全球医用人造材料市场报告针对该行业的各个相关人员,如投资者、供应商、产品製造商、经销商、新进入者和财务分析师。
  • 透过用于分析全球医用人造材料市场的各种策略矩阵,将促进相关人员的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规及趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章全球医疗材料市场 - 冠状冠状病毒(COVID-19)大流行的影响

  • 新型冠状病毒感染疾病(COVID-19)的流行病学
  • 供需面分析
  • 经济影响

第五章全球医疗材料市场,依产品类型,2018-2030

  • 介绍
  • 金属生物材料
  • 陶瓷生物材料
  • 高分子生物材料
  • 天然生物材料
  • 复合生物材料
  • 其他的

第六章 全球医疗材料市场,依应用分类,2018-2030

  • 介绍
  • 心血管
  • 整形外科
  • 牙科
  • 整形外科
  • 创伤治疗
  • 神经学的
  • 其他的

第七章 全球医疗材料市场(依最终使用者),2018-2030

  • 介绍
  • 医院
  • 诊所
  • 研究机构
  • 其他的

第八章2018-2030年全球医疗材料市场(按地区)

  • 介绍
  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 东南亚国协
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲

第9章 中东/非洲

    • 2019-2030 年市场规模与按产品类型预测、与前一年同期比较成长率
    • 2019-2030 年市场规模与应用预测、与前一年同期比较成长率
    • 2019-2030 年市场规模与最终用户预测、与前一年同期比较成长率
    • 2019-2030年各国市场规模及预测、与前一年同期比较成长率
  • 海湾合作委员会国家
  • 以色列
  • 南非
  • 中部非洲
  • 北非
  • 其他中东地区

第10章竞争形势

  • Evonik Industries AG
  • Covestro AG
  • BASF SE
  • Solvay
  • SABIC
  • Trelleborg AB
  • DSM
  • Celanese Corporation
  • DuPont de Nemours Inc.
  • Others

第11章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6308

Global medical engineered materials market is expected to reach US$ 50.11 Bn by 2030, from US$ 19.66 Bn in 2023, exhibiting a CAGR of 14.3% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023/2024: US$ 19.66 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR: 14.30% 2030/2031 Value Projection: US$ 50.11 Bn
Figure 1. Global Medical Engineered Materials Market Share (%), By Region, 2023
Medical Engineered Materials Market - IMG1

Medical engineered materials play a crucial role in the healthcare industry, and provides innovative solutions for a wide range of applications. These materials are specifically designed to meet the unique requirements of medical devices, implants, and equipment. These offer exceptional strength, durability, and biocompatibility, ensuring safe and effective healthcare solutions. There has been significant advancement in materials science and engineering which has expanded the use of materials like ceramics, metals, polymers, and composites in healthcare. Newer bioengineered materials are being developed that can closely mimic human tissues and aid in tissue regeneration. The advances are driven by the need for improved patient outcomes along with increasing complexity of medical procedures and treatments. Overall, the medical engineered materials industry plays a crucial role in developing innovative materials solutions that can elevate healthcare to the next level.

Market Dynamics:

Global medical engineered materials market growth is driven by several factors. Increasing prevalence of chronic diseases such as cardiovascular disorders, diabetes, and cancer is expected to boost demand for medical devices and implants. These materials offer exceptional properties including biocompatibility, durability, and flexibility, which are crucial in the development of advanced medical devices. Rising geriatric population worldwide is contributing to the market growth. The elderly population is more susceptible to chronic diseases and requires specialized medical treatments, which necessitate the use of medical engineered materials. Moreover, technological advancements in material science, such as the development of bio-based materials and nanotechnology-based coatings, are further driving market growth.

However, the market faces few challenges. Stringent regulations and quality standards imposed by regulatory authorities, such as the U.S. Food and Drug Administration (FDA), can pose hurdles for market players. Compliance with these regulations and obtaining regulatory approvals for new materials can be time-consuming and costly. Furthermore, the high cost associated with the development and manufacturing of medical engineered materials can act as a restraint for market growth.

Key features of the study:

  • This report provides in-depth analysis of the global medical engineered materials market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global medical engineered materials market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Evonik Industries AG, Covestro AG, BASF SE, Solvay, SABIC, Trelleborg AB, DSM, Celanese Corporation, DuPont de Nemours Inc.,
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global medical engineered materials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical engineered materials market

Medical Engineered Materials Market Detailed Segmentation:

  • By Product Type
    • Metallic Biomaterials
    • Ceramics Biomaterials
    • Polymeric Biomaterials
    • Natural Biomaterials
    • Composites Biomaterials
    • Others
  • By Application
    • Cardiovascular
    • Orthopedic
    • Dental
    • Plastic Surgery
    • Wound Healing
    • Neuro-logical
    • Others
  • By End User
    • Hospitals
    • Clinics
    • Research Institutions
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Top companies in Global Medical Engineered Materials Market:
    • Evonik Industries AG
    • Covestro AG
    • BASF SE
    • Solvay
    • SABIC
    • Trelleborg AB
    • DSM
    • Celanese Corporation
    • DuPont de Nemours Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Medical Engineered Materials Market, By Product Type
    • Medical Engineered Materials Market, By Application
    • Medical Engineered Materials Market, By End User
    • Medical Engineered Materials Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing prevalence of chronic diseases
    • Stringent clinical & regulatory requirements
    • Applications in personalized medicine
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Medical Engineered Materials Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Medical Engineered Materials Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Metallic Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Ceramics Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Polymeric Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Natural Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Composites Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030, (US$ Bn)

6. Global Medical Engineered Materials Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Orthopedic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Dental
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Plastic Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Wound Healing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Neuro-logical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)

7. Global Medical Engineered Materials Market , By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Research Institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)

8. Global Medical Engineered Materials Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2018 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2030, (US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2030, (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2030, (US$ Bn)
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America

9. Middle East & Africa

  • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2030, (US$ Bn)
  • GCC Countries
  • Israel
  • South Africa
  • Central Africa
  • North Africa
  • Rest of Middle East

10. Competitive Landscape

  • Evonik Industries AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Covestro AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BASF SE
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Solvay
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • SABIC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Trelleborg AB
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • DSM
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Celanese Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • DuPont de Nemours Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Others
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us